OzeScribe, founded in 2003, is a provider of medical transcription services in Australia. Based on the principals of its founders, OzeScribe focuses on delivering accurate documentation in a timely fashion through the utilization of domestic resources.
Missing: OzeScribe's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: OzeScribe's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing OzeScribe
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
OzeScribe is included in 1 Expert Collection, including Clinical Encounter Tech.
Clinical Encounter Tech
Latest OzeScribe News
Jan 6, 2016
× Leader in Health Information and Clinical Documentation ATLANTA, Jan. 6, 2016 /PRNewswire/ -- iMedX Australia Pty Ltd., (iMedX) announced today that it has completed the acquisition of OzeScribe, Pty Ltd. (OzeScribe), the leading medical transcription and documentation service provider in Australia. As an established and successful market leader with an outstanding reputation, OzeScribe will serve as the foundation for iMedX's long-term growth strategy aimed at fusing innovative technology with unparalleled experience to give clients a significant edge in the clinical documentation process. "iMedX and OzeScribe share a strong commitment to improving the service we provide," said Lyndie Arkell, Founder and CEO of OzeScribe. "This combination will further strengthen our ability to service customers and meet their needs while maintaining our current Australian-based operations. " In addition to its continuously growing technological capabilities, iMedX's wealth of resources and sophisticated infrastructure will provide OzeScribe support services not previously available and allow the company's personnel to focus on servicing and growing its clientele base. "This acquisition is a win for both companies," said Dr. Tony Arkell, Medical Director of OzeScribe. "The broader range of technologies and services made available through this complementary alliance will allow us to develop a more secure Australian-based data storage system and introduce a new breadth of technological solutions. " As a result, the combined companies will be well positioned to ensure higher quality results and performance, while also supporting clients' goals for operational cost reductions at each stage of the transcription process. "We are thrilled to welcome the OzeScribe team to our iMedX family," said Christopher Foley, CEO of iMedX. "The combination of our companies' unique strengths and resources will allow us to provide an increased level of service and success for clients worldwide. We are excited for this opportunity to further compete in the global marketplace as a result. " The combined companies make up the one of the largest global clinical documentation service providers and share an ultimate goal of driving positive results and success for healthcare clients worldwide. The companies will work together to service and support their collective client base and remain dedicated to the individual success of customers. ABOUT IMEDX Founded in 2002, iMedX is an integrated medical document management and health information solutions company based in Atlanta, GA. Through its continuously growing technological capabilities, iMedX offers a full suite of high-value revenue cycle management solutions including medical transcription, medical coding services, results-based consulting, and data analytics. For more information, visit iMedX online at www.imedx.com or call 404-418-0096. ABOUT OZESCRIBE Founded in 2003, OzeScribe is the leading provider of medical transcription services in Australia. Based on the principals of its founders, OzeScribe focuses on delivering accurate documentation in a timely fashion through the utilization of domestic resources. For more information, visit OzeScribe online at www.ozescribe.com.au . MEDIA CONTACT
OzeScribe Frequently Asked Questions (FAQ)
Where is OzeScribe's headquarters?
OzeScribe's headquarters is located at 354 Tooronga Road, Glen Iris.
What is OzeScribe's latest funding round?
OzeScribe's latest funding round is Acquired.
Who are the investors of OzeScribe?
Investors of OzeScribe include iMedX.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.